BLTE.NASDAQBelite Bio, INC
Form 4: Belite Bio CEO Sells Shares
Sentiment:
Insider Transaction (Form 4)
Yu-Hsin Lin, Chief Executive Officer and a Director of Belite Bio, Inc, sold 100,435 shares of common stock on September 4, 2026.
Summary
- Open-market sale: disposed of 2,635 American depositary share at $180.29 ($475,071) on September 4, 2026; holds 167,934 after (Direct).
- Open-market sale: disposed of 2,587 American depositary share at $181.24 ($468,877) on September 4, 2026; holds 165,347 after (Direct).
- Open-market sale: disposed of 3,413 American depositary share at $182.50 ($622,869) on September 4, 2026; holds 161,934 after (Direct).
- Open-market sale: disposed of 4,955 American depositary share at $183.30 ($908,228) on September 4, 2026; holds 156,979 after (Direct).
- Open-market sale: disposed of 6,252 American depositary share at $184.52 ($1,153,647) on September 4, 2026; holds 150,727 after (Direct).
- Open-market sale: disposed of 4,593 American depositary share at $185.34 ($851,286) on September 4, 2026; holds 146,134 after (Direct).
- Open-market sale: disposed of 7,800 American depositary share at $186.32 ($1,453,323) on September 4, 2026; holds 138,334 after (Direct).
- Open-market sale: disposed of 6,200 American depositary share at $187.25 ($1,160,964) on September 4, 2026; holds 132,134 after (Direct).
- Open-market sale: disposed of 3,045 American depositary share at $188.26 ($573,253) on September 4, 2026; holds 129,089 after (Direct).
- Open-market sale: disposed of 8,955 American depositary share at $189.34 ($1,695,552) on September 4, 2026; holds 120,134 after (Direct).
- Open-market sale: disposed of 600 American depositary share at $190.39 ($114,232) on September 4, 2026; holds 119,534 after (Direct).
- Open-market sale: disposed of 11,080 American depositary share at $191.15 ($2,117,909) on September 4, 2026; holds 108,454 after (Direct).
- Open-market sale: disposed of 4,209 American depositary share at $192.54 ($810,412) on September 4, 2026; holds 104,245 after (Direct).
- Open-market sale: disposed of 8,111 American depositary share at $193.13 ($1,566,439) on September 4, 2026; holds 96,134 after (Direct).
- Open-market sale: disposed of 2,400 American depositary share at $194.33 ($466,399) on September 8, 2026; holds 93,734 after (Direct).
- Open-market sale: disposed of 6,090 American depositary share at $195.62 ($1,191,325) on September 8, 2026; holds 87,644 after (Direct).
- Open-market sale: disposed of 6,058 American depositary share at $196.54 ($1,190,642) on September 8, 2026; holds 81,586 after (Direct).
- Open-market sale: disposed of 8,752 American depositary share at $197.36 ($1,727,275) on September 8, 2026; holds 72,834 after (Direct).
- Open-market sale: disposed of 2,700 American depositary share at $198.09 ($534,845) on September 8, 2026; holds 70,134 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $19,082,549 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Yu-Hsin Lin — Director, Officer (Chief Executive Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-04 | Open-market sale | American depositary share | 2,635 | $180 | $475.1K | 167,934 |
| 2026-09-04 | Open-market sale | American depositary share | 2,587 | $181 | $468.9K | 165,347 |
| 2026-09-04 | Open-market sale | American depositary share | 3,413 | $182 | $622.9K | 161,934 |
| 2026-09-04 | Open-market sale | American depositary share | 4,955 | $183 | $908.2K | 156,979 |
| 2026-09-04 | Open-market sale | American depositary share | 6,252 | $185 | $1.2M | 150,727 |
| 2026-09-04 | Open-market sale | American depositary share | 4,593 | $185 | $851.3K | 146,134 |
| 2026-09-04 | Open-market sale | American depositary share | 7,800 | $186 | $1.5M | 138,334 |
| 2026-09-04 | Open-market sale | American depositary share | 6,200 | $187 | $1.2M | 132,134 |
| 2026-09-04 | Open-market sale | American depositary share | 3,045 | $188 | $573.3K | 129,089 |
| 2026-09-04 | Open-market sale | American depositary share | 8,955 | $189 | $1.7M | 120,134 |
| 2026-09-04 | Open-market sale | American depositary share | 600 | $190 | $114.2K | 119,534 |
| 2026-09-04 | Open-market sale | American depositary share | 11,080 | $191 | $2.1M | 108,454 |
| 2026-09-04 | Open-market sale | American depositary share | 4,209 | $193 | $810.4K | 104,245 |
| 2026-09-04 | Open-market sale | American depositary share | 8,111 | $193 | $1.6M | 96,134 |
| 2026-09-08 | Open-market sale | American depositary share | 2,400 | $194 | $466.4K | 93,734 |
| 2026-09-08 | Open-market sale | American depositary share | 6,090 | $196 | $1.2M | 87,644 |
| 2026-09-08 | Open-market sale | American depositary share | 6,058 | $197 | $1.2M | 81,586 |
| 2026-09-08 | Open-market sale | American depositary share | 8,752 | $197 | $1.7M | 72,834 |
| 2026-09-08 | Open-market sale | American depositary share | 2,700 | $198 | $534.8K | 70,134 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-04 | Open-market sale (2,635 shares) |
| 2026-09-04 | Open-market sale (2,587 shares) |
| 2026-09-04 | Open-market sale (3,413 shares) |
| 2026-09-04 | Open-market sale (4,955 shares) |
| 2026-09-04 | Open-market sale (6,252 shares) |
| 2026-09-04 | Open-market sale (4,593 shares) |
| 2026-09-04 | Open-market sale (7,800 shares) |
| 2026-09-04 | Open-market sale (6,200 shares) |
| 2026-09-04 | Open-market sale (3,045 shares) |
| 2026-09-04 | Open-market sale (8,955 shares) |
| 2026-09-04 | Open-market sale (600 shares) |
| 2026-09-04 | Open-market sale (11,080 shares) |
| 2026-09-04 | Open-market sale (4,209 shares) |
| 2026-09-04 | Open-market sale (8,111 shares) |
| 2026-09-08 | Open-market sale (2,400 shares) |
| 2026-09-08 | Open-market sale (6,090 shares) |
| 2026-09-08 | Open-market sale (6,058 shares) |
| 2026-09-08 | Open-market sale (8,752 shares) |
| 2026-09-08 | Open-market sale (2,700 shares) |
Keywords
insider transaction, Form 4, BLTE, BELITE BIO, INC, bearish, Yu-Hsin Lin
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.